
Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis
Keywords: کیفیت زندگی مرتبط با سلامت; age; body mass index; body weight; disease duration; health-related quality of life; race; symptom severity; tumor necrosis factor antagonistAE, adverse event; BMI, body mass index; BSA, body surface area; PASI, Psoriasis Area and Severity Index; PASI 75,